Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cary J. G. Oberije"'
Autor:
Iva Halilaj, Anshu Ankolekar, Anouk Lenaers, Avishek Chatterjee, Cary J. G. Oberije, Lisanne Eppings, Hans J. M. Smit, Lizza E. L. Hendriks, Arthur Jochems, Relinde I. Y. Lieverse, Janita E. van Timmeren, Anke Wind, Philippe Lambin
Publikováno v:
Frontiers in Digital Health, Vol 5 (2024)
The aim of this study was to develop and evaluate a proof-of-concept open-source individualized Patient Decision Aid (iPDA) with a group of patients, physicians, and computer scientists. The iPDA was developed based on the International Patient Decis
Externí odkaz:
https://doaj.org/article/e12bdf591cc24ee2aa47f5ffbb7db295
Autor:
Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, Yolande Lievens, Monique C. de Jong, Johan Bussink, Xavier Geets, Vincenzo Valentini, Giuliano Elia, Dario Neri, Charlotte Billiet, Amir Abdollahi, David Pasquier, Pierre Boisselier, Ala Yaromina, Dirk De Ruysscher, Ludwig J. Dubois, Philippe Lambin
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background About 50% of non-small cell lung cancer (NSCLC) patients have metastatic disease at initial diagnosis, which limits their treatment options and, consequently, the 5-year survival rate (15%). Immune checkpoint inhibitors (ICI), eit
Externí odkaz:
https://doaj.org/article/3d19c81b16c745a58482aa1902edf103
Autor:
Kecskemethy, Cary J. G. Oberije, Nisha Sharma, Jonathan J. James, Annie Y. Ng, Jonathan Nash, Peter D.
Publikováno v:
Cancers; Volume 15; Issue 12; Pages: 3069
Invasiveness status, histological grade, lymph node stage, and tumour size are important prognostic factors for breast cancer survival. This evaluation aims to compare these features for cancers detected by AI and human readers using digital mammogra
Autor:
Zheng Feng, Cary J. G. Oberije, Alouisa J. P. van de Wetering, Alexander Koch, Kim. A. D. Wouters, Nathalie Vaes, Ad A. M. Masclee, Beatriz Carvalho, Gerrit A. Meijer, Maurice P. Zeegers, James G. Herman, Veerle Melotte, Manon van Engeland, Kim M. Smits
Publikováno v:
Clinical and Translational Gastroenterology, 13(6):e00499. Nature Publishing Group
OBJECTIVES: To improve colorectal cancer (CRC) survival and lower incidence rates, colonoscopy and/or fecal immunochemical test screening are widely implemented. Although candidate DNA methylation biomarkers have been published to improve or compleme